Oncogenic<i>CSF3R</i>Mutations in Chronic Neutrophilic Leukemia and Atypical CML

2013562 citationsJournal Articlebronze Open Access

Authors

Julia E. Maxson · Oregon Health & Science University

Jason Gotlib · Stanford University

Daniel A. Pollyea · University of Colorado Denver

Angela G. Fleischman · OHSU Knight Cancer Institute

Anupriya Agarwal · OHSU Knight Cancer Institute

Christopher A. Eide · OHSU Knight Cancer Institute

Daniel Bottomly

Abstract

Mutations in CSF3R are common in patients with CNL or atypical CML and represent a potentially useful criterion for diagnosing these neoplasms. (Funded by the Leukemia and Lymphoma Society and others.).

Topics & Keywords

Myeloproliferative Neoplasms: Diagnosis and Treatment Acute Myeloid Leukemia Research Chronic Myeloid Leukemia Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 368, Issue 19, pp. 1781-1790

DOI: 10.1056/nejmoa1214514

Field-Weighted Citation Impact: 28.00